Sharon Hodgson MP: speeches
Sharon Hodgson MP: full overview
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Parliamentary contributions: dates and coverage
- Source checked
- 19 Nov 2026
- Last successful import
- 19 Nov 2026
- Records dated through
- 18 Nov 2026
- Selected period
- Reporting year 2: 4 Jul 2025 to 3 Jul 2026
- Completeness
- Published snapshot: 20,988 records in the source window 21 Aug 2026 to 19 Nov 2026. The published snapshot covers its stated source window. Older imports can extend beyond it; not every public speech is included.
This page lists the parliamentary spoken contributions we hold for Sharon Hodgson in the reporting year 2 (4 Jul 2025 to 3 Jul 2026). It does not include every public speech, party-conference address or constituency event. Latest retained contribution in this period: 2 Jul 2026. The source check date and dataset limits are shown above. Open the Hansard link for the full debate and surrounding context.
Read what this MP said, asked and contributed in Parliament.
13 published records · newest first.
Speeches
- 2 Jul 2026 · Heart Disease and Stroke: Premature Deaths · Read the full contribution in Hansard
More
As with all medication, it is obviously up to GPs to consider side effects when prescribing. Some side effects might be apparent sooner rather than later, but they are definitely conversations that patients need to have closely and quickly with prescribers and GPs. I encourage all constituents to be cognisant of side effects and not just hope that they will go away or that they do not matter. They should always be raised with their GP.
- 25 Jun 2026 · Neuropsychiatric Conditions: PANS and PANDAS · Read the full contribution in Hansard
More
I thank the hon. Member for North East Fife (Wendy Chamberlain) and the Backbench Business Committee for bringing forward today’s debate. I think we can all agree that, although the number of attendees has been small, it has been mighty in terms of the quality of contributions we have heard from hon. Members. I am also grateful for the opportunity to speak today on the subject of PANS/PANDAS. As hon.
- 15 Jun 2026 · Brain Cancer · Read the full contribution in Hansard
More
I will come back to the hon. Gentleman’s point. I really do have to get through some things and respond to the number of people who spoke about brain cancer research, because nearly all hon. Members mentioned that. Through the National Institute for Health and Care Research, we have directly invested more than £32 million since the general election. My hon.
- 22 Apr 2026 · Sudden Unexpected Death in Epilepsy · Read the full contribution in Hansard
More
I welcome the development of the Clive Treacey safety checklist. It is an important part of Clive’s legacy, notwithstanding the comments that my hon. Friend made about his legacy being much wider than that.
- 13 Apr 2026 · Young Cancer Patients: Experiences and Outcomes · Read the full contribution in Hansard
More
I thank my hon. Friend for that important intervention. I will also commit to meeting him and the young people he mentions, perhaps in co-ordination with my visit to the Teenage Cancer Trust. I hope there will be plenty of opportunity to meet young people during that visit. It is a yes to both of those requests.
- 26 Mar 2026 · Ehlers-Danlos Syndrome and Craniocervical Instability · Read the full contribution in Hansard
More
I did touch on research, but I did not specifically mention universities. I am pleased that the hon. Member got in another plug for the wonderful Queen’s University Belfast—he did that when we were in this Chamber the other day—and I will take his point on board. I thank him for that. In closing, I return to the people at the heart of this debate: those living with EDS and CCI.
- 26 Mar 2026 · Ehlers-Danlos Syndrome and Craniocervical Instability · Read the full contribution in Hansard
More
I thank the hon. Gentleman on behalf of his constituent, Natasha, and I will make sure that I include her name later when I come on to name everyone referred to during the debate. I also thank him for managing to juggle and spin all the plates that we have to deal with as Members by making time to come along to this debate. I also thank all the other hon.
- 24 Mar 2026 · Sudden Unexplained Death in Childhood · Read the full contribution in Hansard
More
Yes. I thank the hon. Member for his very moving speech; he often moves me to tears in moments such as this. I will take that away, and ask my officials to look at the work of Queen’s University Belfast, because he makes a very important point. The shadow Minister, the hon. Member for Sleaford and North Hykeham (Dr Johnson), made a couple of points.
- 24 Mar 2026 · Endometriosis Services · Read the full contribution in Hansard
More
Yes—I or my colleague in the Department will undertake to look at that and ensure the hon. Lady receives a response. In response to questions on data and research raised by my hon. Friend the Member for Hampstead and Highgate (Tulip Siddiq), and the hon. Members for Strangford (Jim Shannon) and for Bath (Wera Hobhouse), the Department, through the National Institute for Health and Care Research, has commissioned several studies focused on endometriosis diagnosis, treatment and patient experience.
- 24 Mar 2026 · Endometriosis Services · Read the full contribution in Hansard
More
It is a pleasure to serve under your chairmanship, Mr Dowd. I congratulate my hon. Friend the Member for Ipswich (Jack Abbott) on securing this very important debate. I am honoured to respond to it on behalf of my hon. Friend the Minister for Secondary Care, who unfortunately cannot be here today—this area of policy would normally fall under her portfolio.
- 23 Mar 2026 · Tobacco and Vapes Bill · Read the full contribution in Hansard
More
The freedom to be addicted—I think that is what the hon. Member has just defended. I am sure that those on his Front Bench will take note of that. He also asked me about smokefree places. No smoker wants to harm people, but they do so through second-hand smoke, as we all know. On 13 February, the Government published our consultation on “free from” places.
- 9 Mar 2026 · Type 1 Diabetes: Infant Testing · Read the full contribution in Hansard
More
If I may, I will write to the hon. Member on his important point, rather than giving a possibly unsatisfactory answer off the top of my head. The NHS is exploring how IT can be better used to support GPs in making more accurate diagnoses. That includes how existing electronic patient record—EPR— systems could be used more effectively to provide prompts for GPs to consider type 1 diabetes when particular symptoms are added.
- 9 Mar 2026 · Type 1 Diabetes: Infant Testing · Read the full contribution in Hansard
More
That might be a fair point on some treatments more widely, but funding is not an issue for the finger-prick test—it is very affordable for the NHS, and I am told that funding is not the issue on the point we are debating today. I am pleased that NICE has been able to respond very quickly to Mr and Mrs Story. It has engaged with them in detail and listened to their concerns about how the guidance could be clearer.
Explore activity by topic or department
Contributions by debate topic
4 Jul 2025–3 Jul 2026. Existing keyword taxonomy applied to official debate titles and contributions; a contribution may appear in more than one topic and unclassified records are retained.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →